heart attack news from FierceBioResearcher
News
Researchers testing stem cell therapy for CHF
Researchers in Florida are beginning a small, early-stage human trial to test a new stem cell therapy for congestive heart failure. The physicians are taking premature muscle cells--called Read more...
Researchers see FDA uncertainty behind hold on ESC work
The news that the FDA had put a ‘clinical hold' on Geron's plans to launch the first U.S. clinical trial of a stem cell therapy is attracting considerable scrutiny from researchers. The
Read more...Geron aims to be first in human trials with ESCs
In a first, Geron made headlines at the BIO CEO conference in New York with its announcement that it could begin its first human trials using embryonic stem cells to treat spinal cord injuries as Read more...
ESC 'patch' could heal heart attack damage
Scientists at London's Imperial College have developed a patch made from embryonic stem cells to repair damaged hearts. The team matured human heart cells in a lab dish and then created a patch out Read more...
ALSO NOTED: Debate over ESC research still hot; Nanotech devices used to track cancer; Investigators race to find COPD genes;
Stem Cell Research The recent news that scientists were able to take skin cells and make them act with all the versatility of embryonic stem cells has done nothing to tamp down the fierce debate over Read more...
Geron: Stem cells repair heart attack damage
Researchers from Geron and the University of Washington have completed new animal studies that offer fresh evidence Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets